Emerging Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report By Application (Laboratory Testing and Point-of-Care Testing), Technology, Type of Infection, Disease Type, End Users, Region, And Segment Forecasts, 2023-2031
Emerging Infectious Disease Diagnostics Market Size is valued at US$ 19.23 Bn in 2022 and is predicted to reach US$ 31.76 Bn by the year 2031 at an 5.9% CAGR during the forecast period for 2023-2031.
Infectious disease diagnosis is a diagnostic procedure in which various diagnostic tools are used to detect and characterise the causative organisms of infectious diseases.
The COVID-19 pandemic certainly affected the market for infectious disease diagnostics. The COVID-19 pandemic has surged the need to develop diagnostic instruments and tests. For instance, in March 2023, QuidelOrtho Corporation received a De Novo Food and Drug Administration (FDA) Authorization for Sofia® 2 SARS Antigen+ FIA. The Sofia 2 SARS Antigen+ FIA is the first rapid antigen test that detects COVID-19. Additionally, in March 2020, BioMedomics introduced a COVID-19 point-of-care (POC) test that can identify antibodies in blood within 15 minutes.
Growth of the infectious disease diagnostics market is mainly driven by the increasing occurrence of infectious diseases such as COVID-19, human immunodeficiency virus (HIV), hepatitis, and influenza, high demand for point-of-care diagnostic tests, technological advancement in the healthcare sector, and rising government funding for diagnostic services. However, the lack of adequate reimbursements and high healthcare costs hamper the growth of the infectious disease diagnostics market.
Competitive Landscape
Some of the Key Players in the Emerging Infectious Disease Diagnostics Market :
- Abbott Laboratories
- Becton, Dickinson and Company
- bioMérieux S.A.
- Bio-Rad Laboratories, Inc.
- Co-Diagnostics, Inc.
- DANAHER CORPORATION
- DiaSorin S.p.A.
- Hoffmann-La Roche Ltd
- Hologic, Inc.
- QIAGEN N.V.
- QuidelOrtho Corporation
- T2 Biosystems, Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- Siemens Healthineers AG
- Other Prominent Players
Market Segmentation:
The Emerging Infectious Disease Diagnostics Market is segmented based on application, technology, type of infection, disease type, and end users. The application segment comprises laboratory testing and point-of-care testing. By technology, the market is segregated into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), immunodiagnostics, and other technologies. By type of infection, the market is categorized into bacterial, viral, fungal, and other infections. The market is classified by disease type into respiratory infections, sexually transmitted infections (STIs), gastrointestinal infections, and other infections. The end users segment has been grouped into hospitals & clinics, diagnostic laboratories, and other end users.
By Application, The Point-Of-Care Testing Segment Records Significant Growth Over The Forecast Period.
Point-of-care (POC) testing for infectious diseases enables immediate & rapid detection and decision-making. POC tests are designed to be simple, easy to use, and suitable for use in many clinical settings. It facilitates diagnosis and timely decision-making with rapid results, often within minutes or hours; this is especially important for infectious diseases, improving patient outcomes and preventing further transmission.
POC tests can help reduce the spread of disease in the region by providing timely and accurate disease detection in resource-constrained environments.
The Next-Generation Sequencing (NGS) Segment Is Expected To Drive The Emerging Infectious Disease Diagnostics Market In The Upcoming Years.
Next-generation sequencing (NGS) has transformed the diagnosis of infectious diseases by enabling high-throughput analysis of genomes. Whole Genome Sequencing (WGS) sequences an organism's entire genome, providing detailed information about genetic mutations, immune responses, and other diseases. It can identify and characterize pathogens, monitor infections, and analyze evolutionary patterns. Other emerging technologies expected to experience significant growth include technologies such as polymerase chain reaction (PCR) and isothermal nucleic acid amplification technology (INAAT).
Bacterial And Viral Infections Register The Highest Growth In The Market.
There are many methods and techniques for detecting the presence of bacteria in clinical specimens. Bacterial infections include respiratory infections such as streptococcal infections and tuberculosis and sexually transmitted infections (STIs) such as syphilis, chlamydia, and gonorrhoea.
Viruses are capable of mutating and, therefore, can cause relapse even after one strain of the virus has been eradicated or brought under control. That's why molecular testing companies focus on developing tests that can diagnose a huge range of viruses. Some common viral infections include COVID-19, hepatitis, influenza, genital herpes, tuberculosis, gastroenteritis, rubella, Zika, Ebola, and others.
Respiratory Infections Are Expected To Lead The Market.
Most molecular diagnostic companies offer tools or tests for detecting bacteria & viruses that cause respiratory diseases. In addition, the COVID-19 outbreak has led manufacturers to develop many tests using traditional & advanced methods such as RT-PCR and modern technologies like RT-LAMP and CRISPR. Many pharmaceutical companies now offer multiplex assays that simultaneously detect respiratory syncytial virus (RSV), influenza A, influenza B, and SARS-CoV-2 in a single assay test.
By End Users, The Hospitals And Clinics Witnessed Growth At A Rapid Rate.
Hospitals and clinics play a key role in the diagnosis of infectious diseases and serve as important centres for patient evaluation and testing. In addition to point-of-care testing (POCT), which provides immediate results for rapid diagnosis and management, hospitals and clinics can rely on laboratory testing for comprehensive analysis. Some medical facilities have their own laboratories equipped with the most modern diagnostic technology, and others cooperate with external diagnostic laboratories for specialised testing. These laboratory facilities use a variety of methods, including molecular techniques such as polymerase chain reaction (PCR) and sequencing, to accurately detect, classify, and analyse infectious agents.
Regionally, North America Led The Emerging Infectious Disease Diagnostics Market In 2022.
The North American emerging infectious disease diagnostics market is estimated to have significant market revenue during the forecast period due to the presence of key players, the high prevalence of infectious diseases, technological advancements in diagnostic instruments, and growing investments in the healthcare sector.
However, the emerging infectious disease diagnostics market in the Asia Pacific is anticipated to be the fastest-growing regional market in the upcoming years. Factors such as the expanding prevalence of infectious diseases, growing government spending in the health sector, well-established healthcare infrastructure, and rising awareness about advanced diagnostic tools contribute to market expansion.
Emerging Infectious Disease Diagnostics Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 19.23 Bn |
| Revenue Forecast In 2031 | USD 31.76 Bn |
| Growth Rate CAGR | CAGR of 5.9 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Application, Technology, Type of Infection, Disease Type, End Users |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Abbott Laboratories, Becton, Dickinson and Company, bioMérieux S.A., Bio-Rad Laboratories, Inc., Co-Diagnostics, Inc., DANAHER CORPORATION, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, Hologic, Inc., QIAGEN N.V., QuidelOrtho Corporation, T2 Biosystems, Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Emerging Infectious Disease Diagnostics Market -
Emerging Infectious Disease Diagnostics Market By Application-
- Laboratory Testing
- Point-of-Care Testing
Emerging Infectious Disease Diagnostics Market By Technology-
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Next-Generation Sequencing (NGS)
- Immunodiagnostics
- Other Technologies
Emerging Infectious Disease Diagnostics Market By Type of Infection-
- Bacterial
- Viral
- Fungal
- Other Infections
Emerging Infectious Disease Diagnostics Market By Disease Type-
- Respiratory Infections
- Sexually Transmitted Infections (STIs)
- Gastrointestinal Infections
- Other Infections
Emerging Infectious Disease Diagnostics Market By End Users -
- Hospitals and Clinics
- Diagnostic Laboratories
- Other End Users
Emerging Infectious Disease Diagnostics Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Emerging Infectious Disease Diagnostics Market Size is valued at US$ 19.23 Bn in 2022 and is predicted to reach US$ 31.76 Bn by the year 2031
Emerging Infectious Disease Diagnostics Market expected to grow at an 5.9% CAGR during the forecast period for 2023-2031.
QuidelOrtho Corporation, T2 Biosystems, Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, and Others.